Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, New York University School of Medicine, New York, New York.
Obstet Gynecol. 2017 Jun;129(6):1031-1034. doi: 10.1097/AOG.0000000000002036.
Transgender individuals, individuals whose gender identity does not align with their sex assigned at birth, undergoing gender-affirming hormonal or surgical therapies may experience loss of fertility. Assisted reproductive technologies have expanded family-building options for transgender men who were assigned female at birth.
Three transgender men underwent oocyte cryopreservation before gender-affirming hormonal therapy. One patient underwent fertility preservation as an adolescent. Two adult patients had children using their cryopreserved oocytes, with the pregnancies carried by their sexually intimate partners.
Transgender men with cryopreserved gametes can build families in a way that affirms their gender identity. Obstetrician-gynecologists should be familiar with the fertility needs of transgender patients so appropriate discussions and referrals can be made.
跨性别者，即其性别认同与其出生时被分配的性别不一致的个体，在接受性别肯定的激素或手术治疗后可能会失去生育能力。辅助生殖技术为那些出生时被指定为女性的跨性别男性扩大了家庭建设的选择。
三位跨性别男性在接受性别肯定的激素治疗前进行了卵母细胞冷冻保存。一位患者在青少年时期进行了生育力保存。两名成年患者使用他们冷冻的卵母细胞生育了孩子，怀孕由他们的性伴侣妊娠。
冷冻保存配子的跨性别男性可以通过一种肯定其性别认同的方式建立家庭。妇产科医生应该熟悉跨性别患者的生育需求，以便进行适当的讨论和转诊。
